4-25413711-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_013367.3(ANAPC4):c.1592A>G(p.Asn531Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000279 in 1,613,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013367.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANAPC4 | NM_013367.3 | c.1592A>G | p.Asn531Ser | missense_variant | 22/29 | ENST00000315368.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANAPC4 | ENST00000315368.8 | c.1592A>G | p.Asn531Ser | missense_variant | 22/29 | 1 | NM_013367.3 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.000171 AC: 26AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000148 AC: 37AN: 250770Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135514
GnomAD4 exome AF: 0.000290 AC: 424AN: 1461160Hom.: 0 Cov.: 30 AF XY: 0.000294 AC XY: 214AN XY: 726854
GnomAD4 genome ? AF: 0.000171 AC: 26AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2023 | The c.1592A>G (p.N531S) alteration is located in exon 22 (coding exon 21) of the ANAPC4 gene. This alteration results from a A to G substitution at nucleotide position 1592, causing the asparagine (N) at amino acid position 531 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at